DK1296686T3 - Praziquanatelsammensætninger til behandling af coccidiesygdomme - Google Patents

Praziquanatelsammensætninger til behandling af coccidiesygdomme

Info

Publication number
DK1296686T3
DK1296686T3 DK01941541T DK01941541T DK1296686T3 DK 1296686 T3 DK1296686 T3 DK 1296686T3 DK 01941541 T DK01941541 T DK 01941541T DK 01941541 T DK01941541 T DK 01941541T DK 1296686 T3 DK1296686 T3 DK 1296686T3
Authority
DK
Denmark
Prior art keywords
compositions
praziquanatelle
coccidia
treatment
praziquantel
Prior art date
Application number
DK01941541T
Other languages
English (en)
Inventor
Thomas J Kennedy
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Application granted granted Critical
Publication of DK1296686T3 publication Critical patent/DK1296686T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/498—Pyrazines or piperazines ortho- and peri-condensed with carbocyclic ring systems, e.g. quinoxaline, phenazine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/06—Antiabortive agents; Labour repressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Anesthesiology (AREA)
  • Biomedical Technology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
DK01941541T 2000-05-23 2001-05-18 Praziquanatelsammensætninger til behandling af coccidiesygdomme DK1296686T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US09/576,791 US6429211B1 (en) 2000-05-23 2000-05-23 Praziquantel compounds for treating diseases due to Sarcocystis Neospora Toxoplasma and Isospora

Publications (1)

Publication Number Publication Date
DK1296686T3 true DK1296686T3 (da) 2006-04-03

Family

ID=24306001

Family Applications (1)

Application Number Title Priority Date Filing Date
DK01941541T DK1296686T3 (da) 2000-05-23 2001-05-18 Praziquanatelsammensætninger til behandling af coccidiesygdomme

Country Status (19)

Country Link
US (2) US6429211B1 (da)
EP (1) EP1296686B1 (da)
JP (1) JP4991076B2 (da)
KR (1) KR100821112B1 (da)
CN (1) CN1250222C (da)
AT (1) ATE310521T1 (da)
AU (1) AU2001274886A1 (da)
BR (1) BR0111014A (da)
CA (1) CA2409926C (da)
DE (1) DE60115237T2 (da)
DK (1) DK1296686T3 (da)
ES (1) ES2252242T3 (da)
HK (1) HK1059894A1 (da)
HU (1) HUP0302330A3 (da)
MX (1) MXPA02011453A (da)
NZ (1) NZ522687A (da)
PL (1) PL202041B1 (da)
WO (1) WO2001089497A2 (da)
ZA (1) ZA200208770B (da)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006061214A1 (en) * 2004-12-10 2006-06-15 Bayer Healthcare Ag Anthelmintic composition
US8563554B2 (en) 2009-03-17 2013-10-22 Concert Pharmaceuticals, Inc. Deuterated pyrazinoisoquinoline compounds
US10137111B2 (en) 2016-08-11 2018-11-27 Adamis Pharmaceuticals Corporation Drug compositions comprising an anti-parasitic and proton pump inhibitor
US11564910B2 (en) 2017-12-08 2023-01-31 Adamis Pharmaceuticals Corporation Drug compositions
US20200138823A1 (en) * 2018-11-02 2020-05-07 Adamis Pharmaceuticals Corporation Drug compositions

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2362539C2 (de) 1973-12-17 1986-05-07 Merck Patent Gmbh, 6100 Darmstadt 2-Acyl-4-oxo-1,2,3,6,7,11b-hexahydro-4H-pyrazino[2,1-a]isochinoline, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
US4447414A (en) 1982-12-21 1984-05-08 Cutter Laboratories, Inc. Carnivore anthelmintics
DE3634755A1 (de) * 1986-10-11 1988-04-14 Bayer Ag Dermale behandlung von wurmerkrankungen der katze mit praziquantel
DE3805660A1 (de) 1988-02-24 1989-09-07 Bayer Ag Substituierte 1,2,4-triazindione, verfahren zu ihrer herstellung und ihre verwendung
DE3826058A1 (de) 1988-07-30 1990-02-08 Bayer Ag Mittel gegen fischparasiten
US4933341A (en) 1988-10-08 1990-06-12 Bayer Aktiengesellschaft Substituted 1,3,5-triazinetriones, for use against parasitic protozoa
US5196562A (en) 1988-10-08 1993-03-23 Bayer Aktiengesellschaft Substituted 1,3,5-triazinetriones, for use against parasitic protozoa
EP0377903A3 (de) 1989-01-09 1991-07-17 Bayer Ag Substituierte Hexahydro-1,2,4-triazindione, Verfahren zu ihrer Herstellung, Zwischenprodukte dafür und ihre Verwendung
CN1044905A (zh) 1989-02-16 1990-08-29 赫彻斯特股份公司 鱼和昆虫寄生虫对抗剂
DE4030042A1 (de) 1990-05-17 1991-11-21 Bayer Ag Verwendung von substituierten 1,2,4-triazindionen
DE4120138A1 (de) 1991-06-19 1992-12-24 Bayer Ag Substituierte hexahydro-1,2,4-triazindione, verfahren zu ihrer herstellung, zwischenprodukte dafuer und ihre verwendung
AUPM969994A0 (en) 1994-11-28 1994-12-22 Virbac S.A. Equine anthelmintic formulations
US5663155A (en) 1994-11-30 1997-09-02 The University Hospital Compositions for the treatment of parasitic infections
JPH0987196A (ja) * 1995-09-25 1997-03-31 Masatoshi Nakano 寄生虫駆除・駆虫剤
US6051604A (en) * 1995-12-07 2000-04-18 The Proctor & Gamble Company Methods and compositions for the prevention and treatment of gastrointestinal disorders
US6180604B1 (en) * 1996-08-21 2001-01-30 Micrologix Biotech Inc. Compositions and methods for treating infections using analogues of indolicidin
AU5529600A (en) * 1999-06-18 2001-01-09 Bayer Aktiengesellschaft Anthelmintic compositions

Also Published As

Publication number Publication date
NZ522687A (en) 2004-07-30
EP1296686B1 (en) 2005-11-23
PL202041B1 (pl) 2009-05-29
DE60115237T2 (de) 2006-06-29
CN1452489A (zh) 2003-10-29
PL360503A1 (en) 2004-09-06
HK1059894A1 (en) 2004-07-23
DE60115237D1 (de) 2005-12-29
ES2252242T3 (es) 2006-05-16
US20020143018A1 (en) 2002-10-03
MXPA02011453A (es) 2003-05-23
ATE310521T1 (de) 2005-12-15
WO2001089497A3 (en) 2002-11-28
BR0111014A (pt) 2003-04-08
HUP0302330A3 (en) 2012-02-28
KR20020097257A (ko) 2002-12-31
CA2409926A1 (en) 2001-11-29
US6429211B1 (en) 2002-08-06
AU2001274886A1 (en) 2001-12-03
ZA200208770B (en) 2003-10-30
CA2409926C (en) 2009-11-03
JP4991076B2 (ja) 2012-08-01
HUP0302330A2 (hu) 2003-11-28
WO2001089497A2 (en) 2001-11-29
JP2003534275A (ja) 2003-11-18
EP1296686A2 (en) 2003-04-02
CN1250222C (zh) 2006-04-12
KR100821112B1 (ko) 2008-04-11

Similar Documents

Publication Publication Date Title
ATE512976T1 (de) Hemmer des hepatitis-c-virus
DE60114994D1 (de) Blutplättchen-adp-rezeptor-inhibitoren
NO20052130L (no) Sterk inhibitor for HCV-serin-protease
EA200500018A1 (ru) Бензконденсированные гетероариламидные производные тиенопиридинов, применяемые в качестве терапевтических агентов, фармацевтические композиции, включающие их, и способы их применения
EA200500723A1 (ru) Соединения бензофурана, композиции и способы лечения и профилактики инфекций, вызванных вирусом гепатита c, и связанных с ним заболеваний
EA200200716A1 (ru) Арилконденсированные азаполициклические соединения
EA200600582A1 (ru) Способы и композиции для лечения вирусного гепатита с
EA200300318A1 (ru) Пептидомиметические ингибиторы протеазы
EA200701296A1 (ru) 3,5-дизамещенные и 3,5,7-тризамещенные 3h-оксазоло- и 3h-тиазоло[4,5-d] пиримидин-2-оны и их пролекарства
ECSP045073A (es) Nuevos derivados de piperazina
EA200001085A1 (ru) 5-аминоиндено [1, 2-с]пиразол-4-оны в качестве противораковых и антипролиферативных агентов
EA200200995A1 (ru) Применение композиций азалидных антибиотиков для лечения или предупреждения бактериальных или протозойных инфекций у млекопитающих
PT1140102E (pt) Compostos de triazinona para tratar doencas causadas por sarcosystis, neospora etoxoplasma
BR0004538A (pt) Combinação eficaz para o tratamento da impotência
DK1296686T3 (da) Praziquanatelsammensætninger til behandling af coccidiesygdomme
DK1140103T3 (da) Ponazuril til behandling af neurologiske og abortfremkaldende sygdomme forårsaget af Coccidia
EA200500398A1 (ru) ПРОЛЕКАРСТВО ИНГИБИТОРА β-ЛАКТАМАЗЫ
DK1337246T3 (da) Anvendelse af 6-dimethylaminomethyl-1-phenylcyclohexanforbindelser til behandling af urininkontinens
DE69817381D1 (de) Zusammensetzung und diese enthaltende pharmazeutische zubereitung für die behandlung von herpes und verwandten viralen infektionen
AR044482A1 (es) Profarmacos inhibidores de beta-lactamasa
EA200200846A1 (ru) Соединения, полезные для лечения или предупреждения заболеваний, опосредуемых альфа-2в-адреноцептором
PA8591201A1 (es) Nuevos derivados que contienen fosforo
LV12459A (lv) Savienojums un farmaceitiskas kompozicijas ar triptazes aktivitates izmainam saistitu slimibu arstesanai